BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2014 11:15:00 AM | Browse: 1825 | Download: 2375
Publication Name World Journal of Pharmacology
Manuscript ID 11336
Country India
ISSN 2220-3192 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Use of eltrombopag in thrombocytopenia of liver disease
Manuscript Source Invited Manuscript
All Author List Vishal Sharma
Funding Agency and Grant Number
Corresponding Author Vishal Sharma, Assistant Professor, Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160011, India. docvishalsharma@gmail.com
Key Words Cirrhosis; Thrombopoietin; Eltrombopag; Romiplostim; Hepatitis; Hepatitis C virus; Splenectomy; Thrombocytopenia
Core Tip Thrombocytopenia associated with liver disease is multifactorial. Eltrombopag, a thrombopoietin agonist, has been found useful in increasing platelet counts in these patients. It has been clinically used to increase platelet counts in cirrhotic patients prior to invasive procedures and in patients with chronic hepatitis C to enable administration of interferon based antiviral therapy. However, there are concerns regarding its safety and possible increased risk of portal vein thrombosis.
Publish Date 2014-12-12 11:14
Citation Sharma V. Use of eltrombopag in thrombocytopenia of liver disease. World J Pharmacol 2014; 3(4): 186-192
URL http://www.wjgnet.com/2220-3192/full/v3/i4/186.htm
DOI http://dx.doi.org/10.5497/wjp.v3.i4.186
Full Article (PDF) WJP-3-186.pdf
Full Article (Word) WJP-3-186.doc